Solving immuno-oncology trial challenges in the COVID-19 eraThe COVID-19 pandemic has placed immense stress on healthcare provision, but the emergency may also make major advances Share XSolving immuno-oncology trial challenges in the COVID-19 erahttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/solving-immuno-oncology-trial-challenges-in-the-covid-19-era/
Making it as an oncology biotech in the UKWe speak to R&D experts to find out how oncology biotechs can get the support they need to Share XMaking it as an oncology biotech in the UKhttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/alderley-park-oncology-biotech-uk/
Helping HCPs navigate the ever-evolving advanced cancer landscapeOPEN Health’s Christine Drewienkiewicz, Sara Black and Annie Rankin on advances in modern oncology and how pharma can Share XHelping HCPs navigate the ever-evolving advanced cancer landscapehttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/helping-hcps-navigate-the-ever-evolving-advanced-cancer-landscape/
Adapting for the future of oncologyExternal pressures and rapid scientific advancements are changing oncology forever, and innovative trials are needed to keep pace. Share XAdapting for the future of oncologyhttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/adapting-future-oncology-icon/
ASCO 2020: Scientific advances & what’s impacting doctors and patientsDespite going virtual due to the COVID-19 pandemic, Jennifer Harris, an immuno-oncology expert from Syneos Health told pharmaphorum’s Share XASCO 2020: Scientific advances & what’s impacting doctors and patientshttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/asco-2020-scientific-advances-and-the-impact-on-doctors-and-patients/
Deep Dive: The Future of OncologyThis year’s ASCO showed us that while COVID-19 might be front and centre of everyone’s minds, the desire Share XDeep Dive: The Future of Oncologyhttps://pharmaphorum.com/views-analysis-oncology/deep-dive-the-future-of-oncology/
Breaking barriers to patient access in rare oncologyAs technological advances unlock a more nuanced understanding of disease – and exciting opportunities for personalised medicine – Share XBreaking barriers to patient access in rare oncologyhttps://deep-dive.pharmaphorum.com/magazine/market-access-2020/breaking-barriers-to-patient-access-in-rare-oncology/
Janssen: ‘Open dialogue’ needed with HTAs to improve accessThe world of life sciences is changing rapidly, and the traditional ways of assessing drugs may no longer Share XJanssen: ‘Open dialogue’ needed with HTAs to improve accesshttps://deep-dive.pharmaphorum.com/magazine/market-access-2020/janssen-open-dialogue-needed-with-htas-to-improve-access/
A novel approach to detecting Alzheimer’s earlyThe grey matter in the brain may hold vital clues for early, accurate detection in Alzheimer’s, and potentially Share XA novel approach to detecting Alzheimer’s earlyhttps://deep-dive.pharmaphorum.com/magazine/market-access-2020/a-novel-approach-to-detecting-alzheimers-early/
